{"abstract":"The Food and Drug Administration (FDA) is announcing a public meeting on the agency's effort to combat counterfeit drugs. The purpose of the meeting is to enable interested individuals, organizations, and other stakeholders to present information on all aspects of the agency's initiative against counterfeit drugs. FDA is particularly interested in hearing about information related to technology, public education, regulatory and legislative issues, and industry and health professional issues. The agency is also inviting vendors of anti- counterfeit technologies relevant to the pharmaceutical industry to display their products for the educational benefit of FDA and attendees. The objective of the meeting is for FDA to gather information to assist FDA's counterfeit drug task force in finalizing its report, which will include recommendations on steps that FDA, other government agencies, and the private sector can take to minimize the risks to the public from counterfeit drugs entering the supply chain.","action":"Notice of public meeting.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2003/09/05/03-22789.html","cfr_references":[],"citation":"68 FR 52772","comment_url":null,"comments_close_on":null,"correction_of":null,"corrections":[],"dates":null,"disposition_notes":null,"docket_ids":["Docket No. 2003N-0361"],"dockets":[],"document_number":"03-22789","effective_on":null,"end_page":52775,"executive_order_notes":null,"executive_order_number":null,"explanation":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2003/09/05/03-22789.xml","html_url":"https://www.federalregister.gov/documents/2003/09/05/03-22789/anti-counterfeit-drug-initiative-public-meeting","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/03-22789?publication_date=2003-09-05","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2003-09-05/03-22789/mods.xml","not_received_for_publication":null,"page_length":4,"page_views":{"count":38,"last_updated":"2026-04-04 14:15:05 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2003-09-05/pdf/03-22789.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":null,"publication_date":"2003-09-05","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2003/09/05/03-22789.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":52772,"subtype":null,"title":"Anti-Counterfeit Drug Initiative; Public Meeting","toc_doc":"Anti-Counterfeit Drug Initiative","toc_subject":"Meetings:","topics":[],"type":"Notice","volume":68}